# Death Receptors, BCL-2 and Caspases

> How does a cell keep a machine for its own destruction ready to fire within hours, and never fire it by accident? You will tell apoptosis from necrosis, explain how caspases are stored and switched on, and trace the route from a death receptor and the route through the mitochondrion. You will then predict what happens when the BCL-2 brake is too strong or the machinery is missing.

Course: Cell Signaling (Channels, the nucleus, and life or death). Level: advanced university and graduate. About 14 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/death-receptors-bcl2-caspases/

Builds on: Stress Signals: p38 and JNK, p53, Unfolded Proteins and Oxidants · Adaptors, Docking Proteins and Scaffolds

## What you'll learn

- Distinguish apoptosis from necrosis and explain why an animal cell carries a program for its own death.
- Explain how caspases are stored as precursors, switched on by gathering or by cutting, and why their cuts cannot be reversed.
- Trace the outside route (Fas, FADD, caspase-8) and the inside route (BH3-only proteins, BAX and BAK, cytochrome c, APAF-1, caspase-9), and describe the BCL-2 family as a balance.
- Predict what follows when the program is blocked, by excess BCL-2 or by loss of a caspase, and how a BH3-shaped drug or necroptosis changes the outcome.

**Cytochrome c, the small protein you met carrying electrons to complex IV, has a second job: once it leaves the mitochondrion, it is the order for the cell to take itself apart.** A cell that can destroy itself within hours must be certain never to do so by mistake. This lesson asks what the killing enzyme is and what holds it off, and then how a signal from outside the cell or from inside it lets it go.

## The idea: a cell can die by accident or by program

In the early 1960s John Kerr, a doctoral student in London, tied off blood vessels to part of a rat’s liver and studied how the starved cells died. Over the following years he found two deaths in one tissue. In the first, sheets of cells swelled, burst and spilled their contents. That is **necrosis**, death by injury, and the spill often causes inflammation. In the second, single cells scattered through working liver shrank, grew dense and broke into parcels wrapped in unbroken membrane. Neighbouring cells ate the parcels, and no inflammation followed.

*Figure (AI-generated illustration).* Two deaths in one tissue. A necrotic cell swells, bursts and spills, and the spill often causes inflammation. An apoptotic cell shrinks, grows dense and breaks into membrane-wrapped parcels that neighbours eat, and usually no inflammation follows. Image: two panels of three neighbouring cells. In necrosis the middle cell swells, bursts and spills its contents. In apoptosis the middle cell shrinks, dense, and breaks into small parcels wrapped in intact membrane, one of which a neighbour has eaten.

Kerr published the second death in 1971 as “shrinkage necrosis”. In 1972, with Andrew Wyllie and Alastair Currie in Aberdeen, he gave it its own name: **apoptosis**, from a Greek word for the falling of leaves. The name made a claim: this death is something a cell does, as an ordinary part of a tissue’s life.

Why would a cell carry a program for its own death? An animal has to remove cells as well as make them. Development builds cells that are later taken away, and an adult tissue keeps its size only if losses match births. An infected cell, or an immune cell aimed at the body’s own tissues, is safer gone. So there are two groups of apoptosis-involving diseases: too little cell death, as in cancers and autoimmune disease, and too much, as in some forms of neurodegeneration, where apoptosis is one of several ways neurons die.

The proof that such deaths are planned came from a worm. A hermaphrodite, the self-fertilising form of the nematode *Caenorhabditis elegans*, makes 1,090 body cells as it develops, and the same 131 of them die every time. Robert Horvitz’s laboratory hunted for mutants in which the deaths fail. It found two genes needed for nearly all 131 deaths, *ced-3* and *ced-4*, then a brake on them, *ced-9*, and a gene that releases the brake, *egl-1*. Putting two mutations into one animal and seeing which effect won set the genes in order: EGL-1 blocks CED-9, CED-9 holds back CED-4, and CED-4 switches on CED-3. Each has human relatives, which the rest of this lesson follows.

*Figure (AI-generated illustration).* In the worm, EGL-1 blocks CED-9, CED-9 holds back CED-4, and CED-4 switches on CED-3. Double mutants set that order, and each gene has human relatives. Image: a left-to-right chain of four worm gene products, EGL-1 blocking CED-9, CED-9 holding back CED-4 and CED-4 switching on CED-3, ending in a cell breaking into parcels. Small ticks below name the human relatives BCL-2, APAF-1 and caspases.

## The killer is an enzyme kept as a precursor

CED-3 is a protease, and its relatives in your cells are the **caspases**, short for “cysteine-dependent aspartate-specific proteases”. A caspase uses a cysteine in its active site to cut other proteins just after an aspartate.

Every caspase is made as an inactive precursor, a zymogen, like the digestive proteases you know. The caspases that carry out apoptosis come in two kinds. (A third group, the inflammatory caspases such as caspase-1, drives a different, inflammatory death.) **Initiator caspases**, such as caspase-8 and caspase-9, are single inactive chains that become active when a platform gathers several copies and they pair up. **Executioner caspases**, which are caspases 3, 6 and 7, are already paired but stay inactive until an initiator, or another active caspase, cuts them. The first step is a gathering, and every step after it is a cut.

Active executioners cut hundreds of the cell’s proteins, in what is called the demolition phase. One target is the inhibitor of a DNA-cutting enzyme. Freed, that enzyme cuts DNA between nucleosomes, the protein spools that DNA is wound on, and leaves a ladder of fragments about 200 base pairs apart. Other targets support the nucleus and the cytoskeleton, so the chromatin condenses, the cell rounds up and its surface bubbles into blebs.

Compare this with a kinase cascade. A phosphate that a kinase adds, [a phosphatase removes](https://stemhop.com/lessons/phosphorylation-switch). No enzyme rejoins a peptide bond that a caspase has cut. Inhibitor proteins such as X-linked inhibitor of apoptosis protein (XIAP) can restrain an active caspase, and the mitochondrion, when it opens, releases a protein called SMAC that frees caspases from XIAP. But nothing undoes a cut. That is why the main safeguards act earlier, on whether initiators are gathered at all.

## Killed from outside: a death receptor gathers caspase-8

The outside route, called the extrinsic pathway, starts at a **death receptor**: a membrane protein whose tail inside the cell carries a death domain, a small fold that binds other death domains. The best studied is Fas. A killer T cell that has found an infected cell can present Fas ligand, which comes as a trimer and pulls Fas receptors into a cluster.

The clustered tails bind an adaptor, **FADD**. Like [Grb2](https://stemhop.com/lessons/adaptors-and-scaffolds), FADD has no enzyme activity and two binding ends. Its death domain holds Fas, and its death effector domain holds a matching domain on the precursor of caspase-8. Receptor, adaptor and caspase together make the death-inducing signaling complex, or DISC. In it, copies of caspase-8 sit side by side, pair up and become active, and then cut the executioners. The receptor needs no second messenger and no kinase.

*Figure (AI-generated illustration).* A trimeric Fas ligand clusters Fas. FADD, with a death-domain end and a death-effector-domain end, joins the clustered tails to the precursor of caspase-8, and copies of caspase-8 side by side pair up and become active. Counts here are schematic. Image: a three-lobed Fas ligand outside a cell pulls three Fas receptors together in the membrane. Below the membrane, adaptor proteins called FADD link each receptor tail to a caspase-8 precursor, and the stack is bracketed as the DISC. An inset shows two caspase-8 copies paired and active.

Mice showed that animals use this route. Shigekazu Nagata’s laboratory in Osaka cloned human Fas in 1991, starting from an antibody that killed the cells it bound. In 1992 the laboratory found that mice of the lpr strain, kept since the 1970s for their swollen lymph nodes and lupus-like disease, have a defective Fas gene. A second strain with the same disease, gld, proved in 1994 to have a mutation in Fas ligand. Lymphocytes that should have been cleared after an immune response were staying alive.

The receptor for tumor necrosis factor (TNF), TNFR1, has a death domain too, but its usual output is NF-κB and survival, and it kills only when that arm fails. That is “the anti-death, death pathway” of [the NF-κB lesson](https://stemhop.com/lessons/tlr-and-nf-kb).

## Killed from inside: a series of checks and balances

**Film transcript: Cytochrome c, Found in a Test Tube**

### Film transcript: Cytochrome c, Found in a Test Tube

Can a cell's death be made to run in a test tube? In 1996, Xiaodong Wang's laboratory made it happen. They took the soluble contents of HeLa cells. They added the nucleotide dATP. And caspase-3 switched on. Which part of those contents was needed? The laboratory fractionated them. That narrowed the requirement to one small protein. Then came a test. An antibody removed that protein, and the reaction stopped. Then the laboratory added the pure protein back, and the reaction was restored. The protein was cytochrome c. It is the small protein that carries electrons to complex IV. Once it leaves the mitochondrion, it has a second job. The next year, the laboratory purified its partner, APAF-1, a relative of the worm's CED-4. Cytochrome c and dATP make seven copies of APAF-1 assemble into a wheel, the apoptosome.

It gathers caspase-9, as the death-inducing signaling complex gathers caspase-8. Take cytochrome c away, and the reaction stops. Give it back, and it is restored.

Many deaths start inside the cell, with damaged DNA acting through p53, as in the previous lesson, or with the loss of a survival signal. This inside route, the intrinsic pathway, is decided at the outer membrane of the mitochondrion by a family of proteins named for its first member, BCL-2.

BCL-2 was found at a chromosome break. In follicular lymphoma, a cancer of antibody-making B cells, a piece of chromosome 18 is joined to chromosome 14 next to an antibody gene. Yoshihide Tsujimoto in Carlo Croce’s laboratory, and then Stanley Korsmeyer’s laboratory, cloned the junction in 1984 and 1985 and found a gene beside it. In 1988 David Vaux, Suzanne Cory and Jerry Adams in Melbourne showed what the gene does. It does not make cells divide. It keeps them from dying.

In 1993 Korsmeyer’s laboratory found the opposition: BAX, which resembles BCL-2, binds to it, and speeds death. The family is a series of checks and balances with three classes.

- **BAX and BAK** are the effectors. Once activated, they open the outer mitochondrial membrane.
- **BCL-2 and relatives such as BCL-xL** are the guards. They hold BAX and BAK in check.
- **BH3-only proteins**, such as BIM, BID, PUMA, NOXA and BAD, are the sensors of stress. After DNA damage, p53 switches on the genes for PUMA and NOXA. They share with the family only one short helix, the BH3 helix, which fits into a groove on a guard and occupies it. Some, such as BIM and cut BID, can also switch on BAX and BAK directly.

Each sensor has its own control: BAD is switched off when a survival kinase such as [Akt](https://stemhop.com/lessons/pi3k-akt-insulin) phosphorylates it. Korsmeyer read the family as a rheostat: guards and effectors are both present in a healthy cell, and their proportion sets how hard the cell must be pushed.

When BAX and BAK open the membrane, [cytochrome c](https://stemhop.com/lessons/oxidative-phosphorylation) escapes. Xiaodong Wang’s laboratory found what it does next, in 1996, by making apoptosis run in a tube. They took the soluble contents of HeLa cells, added the nucleotide dATP, and saw caspase-3 switch on. Fractionation narrowed the requirement to one small protein. An antibody that removed it stopped the reaction, and adding the pure protein back restored it. It was cytochrome c. The next year the laboratory purified its partner, **APAF-1**, a relative of the worm’s CED-4. Cytochrome c and dATP make seven copies of APAF-1 assemble into a wheel, the **apoptosome**, which gathers caspase-9 as the DISC gathers caspase-8.

The two routes meet. Active caspase-8 cuts the sensor BID, and the cut piece goes to the mitochondrion and releases cytochrome c, as the laboratories of Junying Yuan and Xiaodong Wang reported in 1998. Later work showed that it does so by setting off BAX and BAK.

### Design problem

A cell must be able to destroy itself within hours, and must never do so by accident. Design the safeguards. Say in what form the killing enzyme is kept, what holds it off, and why you would require two separate events before it is released. Then say what a tumour gains by making too much BCL-2, and how a small molecule shaped like a BH3 helix would take that gain away.

> **One way to do it.** Speed means the enzyme must already be made, so store it as a zymogen: an executioner that is inert until it is cut. Give the cut to an initiator that works only when gathered on a platform, and keep the platform’s parts apart: APAF-1 in the cytosol, cytochrome c behind the outer mitochondrial membrane.
>
> Then require two separate events. A stress must switch on BH3-only sensors, and there must be enough of them to tie up the guards, whose level is set separately by survival signals. Suppose noise alone produces each condition in one cell in a thousand. If the two are independent, both arise by chance in one cell in a million. Once the membrane opens in most of the mitochondria, caspases switch on and no cut can be reversed, so the outcome is usually all or none.
>
> A tumour with extra BCL-2 has extra guards. The BH3-only proteins made by damage that would kill a normal cell are soaked up, and the cell lives. A small molecule shaped like a BH3 helix fills the groove on BCL-2 and displaces them. BAX and BAK are freed, and the tumour cell dies of the stress it was already under.

## When the brakes are too strong, or the machinery is missing

The lymphoma has too strong a brake. A B cell with the translocation makes too much BCL-2 and outlives its time, and further mutations can then make it a cancer. The drug venetoclax, approved in the United States in 2016 for a form of chronic lymphocytic leukaemia, is the small molecule of the design problem. It sits in the BH3 groove of BCL-2 and spares the related guard BCL-xL.

Now take the machinery away, in a [knockout mouse](https://stemhop.com/methods/gene-targeting-mice/), one in which a chosen gene has been deleted. Most mice without APAF-1 die before or around birth, and their cells resist many kinds of death signal. Mice without caspase-9 have badly malformed brains with too many cells. So the inside route matters. Yet these embryos get through gastrulation, the early stage at which the body’s layers form, and go on to build organs, and many cells that should die still die. In the webbing between the toes of mice without APAF-1, cells die without the look of apoptosis, by a death that needs no known caspase.

A second backup, separate from that one, sits on the outside route. When TNFR1 is engaged and caspase-8 is blocked, as some viruses arrange, two kinases named RIPK1 and RIPK3 assemble, and RIPK3 phosphorylates a protein called MLKL. MLKL moves to the plasma membrane and breaks it. The cell swells and bursts like a necrotic cell, but on instruction, and the process is called **necroptosis**. Caspase-8 normally restrains it, in part by cutting RIPK1. A mouse embryo without caspase-8 dies, and it survives if RIPK3 is removed as well.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/death-receptors-bcl2-caspases/
